Pricing

Merrill Lynch & Co., Inc. Accel Return Notes Pfizer Inc. due 11/23/2004 (APP)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SECURITY BROKERS, DEALERS & FLOTATION COMPANIES
4 WORLD FINANCIAL CTR NEW YORK, NY 10080

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Are you looking for this stock instead?

Merrill Lynch & Co. Inc. Accelerated Return Notes linked to Pfizer Inc. common stock due 11/23/2004, issued at $25 per unit. The notes will receive no payments before maturity and are not redeemable prior to maturity. At maturity the holder will receive a payment based on the percentage change in the price of Pfizer Inc. common stock, starting value $31.16 as of 9/17/2003.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available